Showing results (761-770 of 1,122) with videos related to
Sort By:
Pageof 113
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1990
Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: a Southwest Oncology Group StudyG E Goodman, J J Crowley, J C Blasko, et al.Journal of Biological Response Modifiers|December 1, 1990
Phase I trial of continuous infusion recombinant interleukin-2 and intermittent recombinant interferon-alpha 2a: clinical effectsR M Bukowski, S Murthy, J Sergi, et al.Cancer|December 20, 2002
Phase I trial of weekly docetaxel and gemcitabine in patients with refractory malignanciesTarek Mekhail, Thomas E Hutson, Paul Elson, et al.Cancer|February 10, 2017
Improving access to high-cost cancer drugs in Latin America: Much to be doneRossana Ruiz, Kathrin Strasser-Weippl, Diego Touya, et al.The Annals of Otology, Rhinology, and Laryngology|September 11, 2025
Eliminating Disparities in Otolaryngology Resident Application SelectionEmily E K Bukowski, Susan E Bisco, Linda X Yin, et al.Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|April 5, 2024
Probing calmodulin-NO synthase interactions via site-specific infrared spectroscopy: an introductory investigationSwapnil Singh, Yadav Prasad Gyawali, Ting Jiang, et al.European Journal of Cancer (Oxford, England : 1990)|July 27, 2010
Long-term safety of sorafenib in advanced renal cell carcinoma: follow-up of patients from phase III TARGETThomas E Hutson, Joaquim Bellmunt, Camillo Porta, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 1998
Phase I trial of subcutaneous recombinant human interleukin-12 in patients with advanced renal cell carcinomaR J Motzer, A Rakhit, L H Schwartz, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1988
Clinical modulation of doxorubicin resistance by the calmodulin-inhibitor, trifluoperazine: a phase I/II trialR L Miller, R M Bukowski, G T Budd, et al.Prevention Science : the Official Journal of the Society for Prevention Research|May 16, 2019
Black Men Who Have Sex with Men and Lifetime HIV Testing: Characterizing the Reasons and Consequences of Having Never Tested for HIVDerrick D Matthews, Jordan M Sang, Cristian J Chandler, et al.Pageof 113